% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Vollmuth:299482,
      author       = {P. Vollmuth$^*$ and P. Karschnia and F. Sahm$^*$ and Y. W.
                      Park and S. S. Ahn and R. Jain},
      title        = {{A} {R}adiologist's {G}uide to {IDH}-{W}ildtype
                      {G}lioblastoma for {E}fficient {C}ommunication {W}ith
                      {C}linicians: {P}art {I}-{E}ssential {I}nformation on
                      {P}reoperative and {I}mmediate {P}ostoperative {I}maging.},
      journal      = {Korean journal of radiology},
      volume       = {26},
      number       = {3},
      issn         = {1229-6929},
      address      = {Seoul},
      publisher    = {Society},
      reportid     = {DKFZ-2025-00442},
      pages        = {246-268},
      year         = {2025},
      note         = {2025 Mar;26(3):246-268},
      abstract     = {The paradigm of isocitrate dehydrogenase (IDH)-wildtype
                      glioblastoma is rapidly evolving, reflecting clinical,
                      pathological, and imaging advancements. Thus, it remains
                      challenging for radiologists, even those who are dedicated
                      to neuro-oncology imaging, to keep pace with this rapidly
                      progressing field and provide useful and updated information
                      to clinicians. Based on current knowledge, radiologists can
                      play a significant role in managing patients with
                      IDH-wildtype glioblastoma by providing accurate preoperative
                      diagnosis as well as preoperative and postoperative
                      treatment planning including accurate delineation of the
                      residual tumor. Through active communication with
                      clinicians, extending far beyond the confines of the
                      radiology reading room, radiologists can impact clinical
                      decision making. This Part 1 review provides an overview
                      about the neuropathological diagnosis of glioblastoma to
                      understand the past, present, and upcoming revisions of the
                      World Health Organization classification. The imaging
                      findings that are noteworthy for radiologists while
                      communicating with clinicians on preoperative and immediate
                      postoperative imaging of IDH-wildtype glioblastomas will be
                      summarized.},
      subtyp        = {Review Article},
      keywords     = {Humans / Glioblastoma: diagnostic imaging / Glioblastoma:
                      surgery / Isocitrate Dehydrogenase: genetics / Brain
                      Neoplasms: diagnostic imaging / Brain Neoplasms: surgery /
                      Magnetic Resonance Imaging: methods / Preoperative Care:
                      methods / Central nervous system neoplasms (Other) /
                      Glioblastoma (Other) / Magnetic resonance imaging (Other) /
                      World Health Organization (Other) / Isocitrate Dehydrogenase
                      (NLM Chemicals)},
      cin          = {E230 / B300 / HD01},
      ddc          = {610},
      cid          = {I:(DE-He78)E230-20160331 / I:(DE-He78)B300-20160331 /
                      I:(DE-He78)HD01-20160331},
      pnm          = {315 - Bildgebung und Radioonkologie (POF4-315)},
      pid          = {G:(DE-HGF)POF4-315},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:39999966},
      doi          = {10.3348/kjr.2024.0982},
      url          = {https://inrepo02.dkfz.de/record/299482},
}